Wyeth (WYE-N) Stock Predictions - Stockchase
WATCH LIST
4
Wyeth (WYE-N)

ON STOCKCHASE SINCE Jun 2004

biotechnology/pharmaceutical

Wyeth

WYE-N

1 watching          
Join the Discussion

Wyeth (WYE-N) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about WYE-N



  • All
  • Filtered
Signal Opinion Expert
BUY
Wyeth(WYE-N) 

November 22, 2006

Pharmaceutical sector is trading at very low valuations. Good growth profile and good portfolio of drugs. Also don’t have the problem of patent expirations that Pfizer does.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Pharmaceutical sector is trading at very low valuations. Good growth profile and good portfolio of drugs. Also don’t have the problem of patent expirations that Pfizer does.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Alex Ruus

Portfolio , Arrow Capital Manage...

Price Price
$48.390
Owned Owned
Yes

BUY
Wyeth(WYE-N) 

July 25, 2006

All the major drug stocks are starting to act better. In this type of market, money moves from risky stocks to defensive stocks. A good place to be.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
All the major drug stocks are starting to act better. In this type of market, money moves from risky stocks to defensive stocks. A good place to be.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$47.470
Owned Owned
No

DON'T BUY
Wyeth(WYE-N) 

July 20, 2005

All the big pharma companies are taking out a lot of costs. The problem is the pipeline is pretty lean, visability is lean. Maybe a little bit of a short term trade up to reward them for the reduced cost structure. Not significant.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
All the big pharma companies are taking out a lot of costs. The problem is the pipeline is pretty lean, visability is lean. Maybe a little bit of a short term trade up to reward them for the reduced cost structure. Not significant.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Danny Tomka

Portfolio , MFC Global Investmen...

Price Price
$46.280
Owned Owned
No

TOP PICK
Wyeth(WYE-N) 

June 4, 2004

Have great new pharmaceutical products they will bring into the market in the 2006/2012 timeframe. 14 X earnings and 2 1/2 percent yield. High quality.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Have great new pharmaceutical products they will bring into the market in the 2006/2012 timeframe. 14 X earnings and 2 1/2 percent yield. High quality.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Brian Rogers

Chief Inve, T. Rowe Price...

Price Price
$36.130
Owned Owned
Yes

Showing 1 to 4 of 4 entries
Successfully Saved Company
Successfully Saved Company